Risk of High-Grade Skin Rash in Cancer Patients Treated with Cetuximab – an Antibody against Epidermal Growth Factor Receptor: Systemic Review and…

Conclusion: Cancer patients who received cetuximab have a substantial risk of developing high-grade skin rash. The risk may be particularly increased in patients with CRC. Further studies are strongly recommended for the prevention and treatment of high-grade skin rash

See the rest here:
Risk of High-Grade Skin Rash in Cancer Patients Treated with Cetuximab – an Antibody against Epidermal Growth Factor Receptor: Systemic Review and…

Related posts:

1. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer Conclusion During the treatment with EGFRI, it is necessary to...
2. Irinotecan associated with cetuximab given every 2 weeks versus cetuximab weekly in metastatic colorectal cancer Conclusion</b> : There is no major difference of efficacy and...
3. Acne bacteria could reduce prostate cancer risk Australian researchers have found a possible link between Propionibacterium acnes...
4. [Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases.] Conclusion: Cetuximab combined wthe either radiotherapy or chemotherapy are good...
5. Severe cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal… DISCUSSION: Our report describes a sudden flare-up of a skin...

Leave a comment

Name (required)

E-mail (required)

URI

Your Message